Abstract. Chinese hamster ovary (CHO) suspension culture cells adhere readily to substrata coated with extracellular matrix proteins such as fibronectin, vitronectin, or laminin. In the case of fibronectin, it is known that adhesion is mediated by an integrin-type, cell surface fibronectin receptor (FnR). We demonstrate here that treatment of CHO cells with submicromolar concentrations of phorbol ester produces a remarkable increase in the ability of these cells to adhere to fibronectin. Both the rate of adhesion and the efficiency of adhesion are enhanced about four-to fivefold. Further, phorbol ester treatment renders the fibronectin-mediated adhesion process less sensitive to inhibitors, including GRGDSP peptide and PB1, a monoclonal anti-FnR antibody. By contrast, nonspecific adhesion processes, for example cell attachment to substrata coated with polylysine or concanavalin A, are not affected by phorbol ester treatment. Thus integrin-mediated adhesion is modulated by phorbol esters, but nonspecific adhesion is not.
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Neither the number of cell surface FnRs nor the receptor affinity, as measured by ~25I-fibronectin and '25I-anti-FnR antibody binding, is altered by phorbol ester treatment. Thus, the effect of phorbol ester on cell adhesion seems to occur at a step subsequent to initial ligand-receptor binding events. Since phorbol ester is a potent activator of protein kinase C, we examined phosphorylation patterns in control and phorbol-treated cells. In immunoprecipitates of lysates from suspension culture cells, there was no evidence of phorbol ester-stimulated phosphorylation of FnR or of talin, a protein thought to interact with FnR. These results suggest that phorbol ester effects on fibronectindependent adhesion are not due to phosphorylation of the FnR itself but rather may be due to postreceptor events, possibly the phosphorylation of cytoskeletal proteins involved in integrin-mediated adhesion.
T HE adhesion of cells to the extracellular matrix is a complex process which involves metabolic and cytoskeletal activities as well as cell surface receptors for matrix macromolecules (11, 29) . Within the last few years two major families of matrix adhesion receptors have been described. The integrin or "cytoadhesin" family (3, 27, 49) is comprised of a number of heterodimeric receptors of ,~ 140 kD in molecular mass. These molecules are involved in a wide variety of cell-matrix and cell-cell adhesive processes in neuronal (18) , immune (56, 57) , connective tissue (7, 14) , and hematopoietic (40, 41) cellular systems. The integrin superfamily includes mammalian receptors for fibronectin (7, 43) , vitronectin (44) , collagen, and laminin (58, 59) . The interactions of many, but not all, integrins with their specific ligands can be inhibited by short peptides containing the RGD adhesive sequence (48, 56, 60) . High affinity mammalian cell receptors for laminin and elastin seem to be members of another family of matrix adhesion receptors (22, 36, 45) . These molecules are in the 65-70-kD range and, in the case of laminin receptor, bind to a YIGSR sequence in the ligand molecule; this type of laminin receptor is found largely in epithelial cells rather than fibroblastic cells (19) . Integrin-type laminin receptors have also been detected in avian cells (24) and in mammalian cells (33, 58) . In addition to the integrin and laminin/elastin receptor families, a number of other apparently distinct matrix adhesion receptors have been described (31, 55) . Furthermore, it is also clear that membrane proteoglycans can play an important role in cell adhesion to extracellular matrix (17) .
It is becoming increasingly certain that receptor-mediated cell adhesion, like many specific cellular processes, is regulated by the action of protein kinases (26, 34) . Thus, oncogenic viruses which express tyrosine kinases have long been known to have profound effects on cell adhesiveness and morphology (13) . Recently, it has been shown that the cytoplasmic domains of some integrins are a target for viral tyrosine kinases (23) and that this may lead to altered interactions between integrins and the cytoskeleton. Serine/threonine kinases also play an important role in the regulation of cell adhesion. Phenomenological effects of cAMP analogues on cell adhesiveness and morphology have been known for many years (13) . Further, we recently have demonstrated a critical role for type I cAMP-dependent protein kinase in the regulation of fibronectin-mediated adhesion (15, 16) . Protein kinase C, an enzyme stimulated by phorbol ester tumor promoters (39) , is also likely to be an important modulator of cell adhesion.
There is a diverse literature on the effects of phorbol esters (these effects presumably mediated by protein kinase C) on cell adhesion and morphology. Thus, in some cases (51), phorbol ester treatment has caused disruption of the cytoskeleton and cell rounding when cells spread on the surface. By contrast, there are many reports indicating that phorbols cause an increase in the adhesiveness of monocytic and granulocytic cells (5, 47) ; this process takes many hours and may involve induced expression of new proteins. With regard to integrin-mediated adhesion, a recent, intriguing report (12) indicates that, in lymphoid ceils treated with phorbol ester, capping of cell surface integrin molecules will lead to cocapping of talin, an internal cytoskeletal component. This suggests a phorbol ester-regulated link between integrins and the cytoskeleton. The relationship of this cocapping process to phorbol ester effects on cell adhesion was not examined. Rothlein and Springer (46) have observed that leukocyte aggregation mediated by LFA-1, a member of the integrin family, is enhanced by phorbol ester treatment. Enhancement of fibronectin-mediated cell spreading and induction of morphological changes by phorbol ester has also been observed in an erythroleukemic cell line (28) .
In this report we have examined effects of phorbol ester (PMA) treatment on the adhesion behavior of suspension cultured Chinese hamster ovary (CHO) ~ cells. This is a useful system for quantitatively studying early events in cell adhesion in a cell population which is not perturbed by the methods one usually uses to dislodge monolayer cells. A preliminary report by Brown (6) indicated that PMA and other agents which stimulate protein kinase C, but not inactive analogues, had a rapid effect on CHO cell adhesion. We show here that PMA treatment produces a rapid and profound enhancement of integrin-mediated cell adhesion, using the fibronectin receptor (FnR) as a model. We further demonstrate that the actions of PMA on adhesion are not due to changes in the cell surface expression or affinity of the FnR. Finally, we show that changes in the phosphorylation state of FnR do not occur subsequent to phorbol ester treatment; indeed, the receptor is a very poor substrate for the kinases present in CHO cells. This suggests that phorbol ester regulation of integrin-mediated cell adhesion is a postreceptor event, probably due to the phosphorylation of cytoskeletal proteins which are involved in this type of adhesion process.
Materials and Methods

Reagents
Cell culture media (alpha MEM), fetal calf serum, and antibiotics (catalogue no. 600-5240AG) were supplied by Gibco Laboratories (Grand Island, NY). PMA, metrizamide, and leupeptin were from Sigma Chemical Co. [32P]gamma ATP (7,000 Ci/mM), and 125I-Bolton-Hunter reagent (2,000 Ci/mM) were from ICN Laboratories, Inc. (Plainview, NY). Bovine albumin fraction V (BSA) was obtained from Miles Laboratories, Inc. (Naperville, [L), protein A-Sepharose 4B was from Pharmacia Fine Chemicals (Piscataway, NJ), Affigel from Bio-Rad Laboratories (Richmond, CA), and Cronex-7 autoradiography film was from DuPont Co. (Wilmington, DE). Bovine plasma fibronectin was prepared as previously described (52, 53) . Vitronectin was prepared from human plasma (50) 
Cells and Adhesion Assays
Wild-type CHO suspension culture cells were grown as previously described (20, 21) . For adhesion assays, exponentially growing cells (105-106/ml) were labeled over night with 35S-translabel (2-5 #Ci/ml), washed in alpha MEM plus 1% BSA, and then used in the assay. Substrata coated with various concentrations of fibronectin, laminin, or vitronectin were prepared in 24-well Costar (Cambridge, MA) polystyrene tissue culture plates as previously described (7); bovine albumin (3 %) was used to block residual protein adsorbtion sites on the plastic. In various experiments, different batches of fibronectin with differing potencies in promoting adhesion were used; thus, internal controls are provided in all experiments. Radiolabeled cells were suspended in alpha MEM plus 1% BSA and allowed to attach to the substrata (0.5 ml/well) during various periods of incubation in a 37°C incubator. Thereafter, unattached cells were removed by washing with alpha MEM plus 1% BSA at 37°C and the residual attached cells lysed with 2% SDS, transferred to scintillation fluid, and counted in a scintillation counter. Results of adhesion assays are expressed either as a percent of the total number of cells or as a percent of positive control (adhesion to substrata in the absence of inhibitors). The number of cells in suspension was measured with a particle counter (ElectroZone Celloscope). In some cases cells were treated, in suspension, with various doses of PMA before the adhesion assay. In most cases a 10-min preincubation period with 1 #M PMA was used and the unbound drug was washed away from the cells before the adhesion process began. The PMA was added as a DMSO solution (fnal concentration in cell suspension was 0.1%; controls contained equivalent amounts of DMSO). The data in adhesion assays represent triplicate independent measurements from at least three separate experiments.
Binding Experiments
Bovine plasma fibronectin was radioiodinated with BoRon-Hunter reagent according to the manufacturer's recommendations, to a specific activity of 1.0-1.5 tzCi/mg protein. Binding of 125I-fibronectin to washed, suspensionculture CHO cells was performed essentially according to the method of Akiyama and Yamada (1, 2), with the following modifications: (a) specific and nonspecific binding were distinguished by use of GRGDSP (2.5 mM) to inhibit specific binding (GLGDSP was used in a concentration, 2.5 mM as an inactive peptide); (b) cells were separated from the ligand by sedimentation (2,500 g) through a layer of 10% metrizamide in alpha MEM plus 1% BSA. Binding was done at 20°C since previous results have indicated little difference in binding at 4°C vs. 20°C (2) and fewer problems with fibronectin aggregation are encountered at 20°C. The level of total t251-fibronectin binding was ,'°20,000 cpm/sample at 135 p.g/ml fibronectin (the highest concentration used), while the level of nonspecific binding was 13,000 cpm/sample. PB1, a specific anti-FnR monoclonal antibody (7) was labeled with t25I-Bolton-Hunter reagent to 100-150 #Cf/mg. Binding of labeled PBI to washed CHO cells was performed at 4°C; a 100x excess of unlabeled PB1 was used to distinguish specific from nonspecific binding, and the excess unbound I25I-antibody was removed by pelleting the cells and washing several times in cold buffer. The Enzfitter (Robin J. Leatherbarrow Ltd., London, UK) program was used to convert binding data to Scatchard plots and to calculate values for binding affinities and number of sites for fibronectin and for PBI. Tissue culture plates were coated with 0.5/~g/ml of fibronectin and then blocked with bovine albumin. CHO cells were prelabeled with 3sS as described in Materials and Methods, treated with PMA (1 izM) or maintained as controls, suspended at 0.5 × 10S/ml in alpha MEM plus 1% BSA, and allowed to adhere at 37°C for different time intervals. The attached cells were recovered and analyzed for radioactivity as described. 
Phosphorylation Experiments Investigation of the Time Course of PMA-induced Phosphorylation of FhR and of Talin. CHO cells preincubated for 2 h with 32pi in alpha MEM
plus serum, were exposed to 1 #M or 100 nM of PMA. Cells were incubated with PMA for various periods at 37°C and then lysed at 4°C for 10 rain with a pH 7.2 lysis buffer containing nonionic detergent and inhibitors of proteolysis and of phosphatases (20 mM Tris, 2 mM sodium vanadate, 40 mM sodium molybdate, 80 mM sodium pyrophosphate, 40 mM potassium phosphate monobasic, 2% Triton X-100, 4 mM EGTA, 2 mM PMSE 0.2 mM trifluoroperazine, 0.2 mM leupeptin). FnR was immunoprecipitated using PBI monoclonal antibody coupled to Aftigel (Bio-Rad Laboratories) (50/zl of gei/ml; PBI-Attigel produced according to Bio-Rad Laboratories recommendations using 2 nag of PB1 per 1 ml of Affigel); talin was precipitated with rabbit antitalin and protein A-Sepharose 4B. In some instances the lysates were precleared with Affigel blocked with ethanolamine. The pellets were dissolved in electrophoresis sample buffer and analyzed by SDS-PAGE (10% acrylamide) according to Laemmli (35) . Gels were transblotted to nitrocellulose; 32P-labeling was detected by autoradiography, while the location of FnR or talin was visualized by immunoblotting with specific antibodies, as described previously (9) or by silver staining.
Additional Whole Cell or Broken Cell Phosphorylation Experiments.
To confirm low molar incorporation of 32Pi into FnR, some incubations were done in phosphate-free medium containing glucose, subsequent to an initial period of depletion of cellular ATP pools by incubation in glucosefree medium. Thus, cells (4 x 108) were washed with buffer A (135 mM NaCI, 3 mM KCI, 20 mM NaHCO3, 10 mg/ml BSA, 1 mM CaCI2, 2 mM MgCI2, 1% antibiotics, pH 7.5), resuspended in 50 ml of the same buffer, and incubated for 4 h at 37°C. Thereafter, cells were sedimented, resuspended in 4 ml of buffer A plus 1 mM adenosine, 12 mM glucose, 2 mCi 32pi, and incubated for 1.5 h at 37°C followed by washing with PBS. CHO cells charged with 32pi were exposed to 1 #M PMA for 10 rain at 37°C and lysed with 5 ml of 100 mM octylglucoside plus phosphatase inhibitors (see above) at 4°C. The lysate supernatant (5,000 g) was precleared with 150 #1 of ethanolamine-blocked Afligel for 2 h at 4°C followed by incubation with 150/zl of PB1-Affigel for the same time. Beads of specific and nonspecific Affigel were exhaustively washed with lysis buffer and bound proteins were solubilized in SDS-containing sample buffer and analyzed by PAGE (35) . In vitro phosphorylatiorl of CHO membrane proteins was performed as follows. Cells (109) were washed in alpha MEM and were swollen in 5 ml of 20 mM Hepes, 10 mM MgCI2, 1% BSA, 2 mM PMSF (buffer B) for 10 rain at 4°C. Cells were broken in a 10-ml glass/glass homogenizer (15 strokes). The homogenate was centrifuged at 500 g for 5 min to remove nuclei and the supernatant was collected and overlaid on 50% sucrose in buffer B and centrifuged at 20000 rpm in a SW 27 rotor (Beckman Instruments, Inc., Fullerton, CA) for 20 rain. The pellet was resuspended in buffer B, homogenized as above, and resedimented through 50% sucrose as above. The final pellet, which contained membrane fragments visible by phasecontrast microscopy, was resuspended in 10 ml of buffer A plus 4 mM NaF, 10 #M ATE 1 mCi gamma [32p]ATP. An aliquot (5 ml) was exposed to 100/~M PMA for l0 min at 37°C while another aliquot was incubated as a control; thereafter, samples were lysed with octylglucoside plus phosphatase inhibitors as above. FnR was precipitated with PB1-Afligel as above.
Results
Effect of PMA on Kinetics and E~ciency of Adhesion to Fibronectin Substrata
The effect of brief treatment with PMA on the rate of adhesion of CHO cells to fibronectin-coated substrata is shown in Fig. 1 A. A concentration of 1 #M PMA causes an approximately fivefold increase in the rate of adhesion. The doseresponse relationship for this effect is shown in Fig. 1 
(A)
at 37°C. The cells in suspension (2 x 10~/ml) were then allowed to adhere in the presence of different concentrations of GRG-DSP-to tissue culture plates coated with 1/tg/ml of fibronectin for 1 h at 37°C. The adherent ceils were recovered and analyzed for radioactivity. Inactive peptide GLGDSP at concentrations of 2 mM had no effect on adhesion (not shown). (B) Inhibition of adhesion by anti-FnR monoclonal antibody. CHO cells were prelabeled with 35S, pretreated with PMA (1 /~M), and allowed to adhere at 1.5 x 105 cells/ml to plates coated with fibronectin (1/~g/ml) for 1 h at 37°C. The medium contained various amounts of PB1 antireceptor monoclonal antibody. Antibody presence in the media of nonimmune mouse IgG in concentrations of 20/zg/ml had no effect on cell adhesion (not shown). (e) PMA treated; (o) control.
adhesion. The characteristics of the PMA dose-response curve shown here are similar to those for protein kinase C activation by PMA (4, 39) . The data of Fig. 1 C demonstrate that PMA treatment causes a marked enhancement of the ability of CHO cells to attach to substrata coated with low concentrations of fibronectin; that is the overall efficiency of fibronectin use is enhanced. Thus, there is approximately a half-log left shift in the dose-response curve for CHO cell adhesion to fibronectin.
PMA Effects on the Potency of lnhibitors of Adhesion to Fibronectin
We next investigated the influence of PMA on inhibition of cell adhesion to fibronectin produced by either anti-FnR antibody or by RGD peptide (42) . As seen in Fig. 2 A, brief pretreatment of cells with PMA causes a marked right shift in the dose-response curve for inhibition by GRGDSE The ICs0 shifts from 0.6 mM for untreated cells to 3.0 mM for PMA-treated cells. In other words, GRGDSP becomes a less potent inhibitor of adhesion with PMA-treated cells. In like manner, PMA treatment causes a pronounced right shift in the inhibition curve for PB1 antibody (Fig. 2 B) . These results coupled with those of Fig. 1 C might be interpreted as an increase in the number or affinity of FnR sites on the cell surface due to PMA treatment. However, this is apparently not the case as indicated below.
PMA Treatment Does Not Directly Affect FnR
We measured the binding of '2sI-PB1 to control cells and to cells treated with PMA under the same circumstances as those which produce enhanced cell adhesion. PB1 is a monoclonal antibody which reacts only with mature, functional FnR and not with other integrins (7-10; also Szeckan, M., and R. L. Juliano, unpublished observations); although we do not know if there is only one PB1 epitope per receptor, nonetheless, the binding of PBI should be proportionate to the number of cell surface receptors. As seen in Fig. 3 A there is no difference in the specific or nonspecific binding of ~2sI-PB1 between control and PMA-treated CHO cells; this finding was confirmed in several independent experiments. Similarly, we measured the binding of ~25I-fibronectin to control and PMA-treated CHO cells. As seen in substrata. Substrata were prepared by coating tissue culture plates for 2 h at 37°C with various concentrations of the indicated protein in PBS and then blocking with albumin (see Materials and Methods). CHO cells were prelabeled with 35S, treated with 1 #M PMA for 10 min at 37°C, or maintained as controls, and allowed to adhere to the substrata for 45 min (A) Polylysine substratum, 4.6 × 3 B there are no differences in specific (GRGDSP-inhibitable) or nonspecific binding of '25I-fibronectin. A number of binding studies were performed, all of which showed no substantial difference in binding parameters. The estimated number of fibronectin binding sites was '~3 × 10÷5/cell, while the Ks was "~-,10 -7 M; this is similar to previously reported results on fibronectin binding (2) . These results indicate that PMA treatment does not directly affect the surface expression or binding characteristics of the FnR. In other systems, phorbol ester treatment has been reported to "modulate" surface receptor expression (32, 38) ; this does not seem to be the case for FnR, at least for the doses and times of exposure used here. Thus, the effects observed in Figs. 1 C and 2, A and B, cannot be ascribed to direct actions of PMA treatment on the binding characteristics of FnR itself. Rather, the effects produced by PMA, presumably mediated via protein kinase C, likely occur within the cell at the postreceptor level of the cell adhesion process.
PMA Affects Integrin-mediated Adhesion but not Nonspecific Adhesion
We wished to investigate whether the action of PMA demonstrated above was restricted to fibronectin-mediated adhesion or if adhesion processes to other substrata were also affected. In addition, we wished to determine if PMA treatment caused diverse effects on the cell membrane which might result in nonspecific adhesion to virtually any type of substratum. To approach these questions, we examined adhesion of CHO cells on substrata coated with polylysine or Con A, where nonspecific cell attachment would likely occur (7). Adhesion of control or PMA-treated CHO cells to nonspecific polylysine-or Con A-coated substrata were virtually identical (Fig. 4, A and B) . A slight shift was noted for Con A, but one should keep in mind that the receptor for fibronectin is a glycoprotein and, along with other membrane glycoproteins, may interact with Con A. Thus, PMA treatment does not markedly affect nonspecific adhesion processes.
Cell adhesion receptors in CHO cells other than the FnR (7-9) have not been well explored. An interesting sidelight of our studies is that CHO cell adhesion to laminin and to vitronectin are also markedly enhanced by PMA treatment (data not shown). This seems similar to recent observations by Kato et al. (30) , who demonstrated PMA enhancement of 3T3 cell adhesion to laminin and to type IV collagen. The nature of the receptors for laminin and vitronectin in CHO cells is undefned at this time, although it seems likely that integrins may be involved.
Lack of Phosphorylation of FnR or Talin Subsequent to PMA Treatment
We wished to investigate whether stimulation of protein kinase C with PMA would result in altered patterns of phosphorylation in CHO cells, especially for FnR itself or for proteins likely to interact with FnR. For example, talin, a known substrate for protein kinase C in vitro (37) , is thought to interact with FnR (11, 25). CHO cells were labeled with [32P]orthophosphate and, in some cases, treated with PMA for various intervals. The FnR and talin were immunoprecipitated from the preparations and examined for PMA-induced phosphorylation as described in Materials and Methods. Phorbol ester-stimulated phosphorylations are known to often display a rapid rise followed by a decline (4, 38) ; thus we examined a range of time points from 0.5 to 20 min. As seen in Fig. 5 , with immunoprecipitation from whole cell extracts, there is no apparent PMA-stimulated phosphorylation of either FnR or talin. Indeed, phosphorylation of FnR is barely detectable with or without PMA treatment; talin phosphorylation is more pronounced but does not change upon PMA treatment at any time point. Thus, there is little evidence that the phosphorylation state of the whole cell pools of talin or of FnR change upon PMA treatment, which is sufficient to promote cell adhesion.
Since some integrins have been reported to be substrates for tyrosine kinases in other systems (23) and since other integrins such as platelet gplIb/IIIa may be substrates for protein kinase C (40a), we were concerned about our inability (Fig. 5) to detect PMA-stimulated phosphorylation of CHO cell FnR. It seemed important to pursue phosphorylation experiments under conditions where chemically detectable amounts of FnR were used and where cell proteins which were suitable substrates for kinases would be strongly labeled with 32pi. For this reason, we examined FnR phosphorylation under conditions which would promote high specific activity of intracellular [32P]ATP pools and intense phosphorylation of suitable protein kinase substrates. We also examined phosphorylation of FnR in a broken cell preparation. This condition should favor intense phosphorylation of susceptible proteins since ample exogenous [32pi]ATP is supplied and since kinases should have good access to all Figure 5 . Lack of PMA-stimulated phosphorylation of FnR or talin in whole cell lysates. CHO cells were preincubated in alpha MEM containing 5% FCS and 32pi (0.1 mCi/ml) at 106 cells/mi in 20 ml of total volume for 3 h at 30°C. Cells then were exposed to 1 tzM PMA or maintained as control for different times at 37°C and lysed with 1 ml of a cold lysis buffer (see Materials and Methods). The intact cell phosphorylation study (Fig. 6 A) clearly demonstrates that FnR is a very poor substrate for those kinases found in CHO cells. The silver stain shows a complex pattern of major and minor bands in the whole cell lysate (Fig. 6 A, lanes I and 2) and a dense band representing FnR in the specific immunoprecipitate (Fig. 6 A, lanes 5 and 6) . The immunoblot with anti-FnR antibody confirms the position of FnR (Fig. 6 A, lanes 13 and 14) . The corresponding autoradiogram shows that several bands in the lysate which are present in relatively modest amounts chemically (Fig. 6 A, lanes I and 2) nonetheless are strongly labeled with 32pi ( Fig. 6 A, lanes 7 and 8) . By contrast, FnR which is quite abundant chemically (Fig. 6 A, lanes 5 and 6) is not detectably labeled with ~2Pi ( Fig. 6 A, l a n e s / / a n d 12). Thus, the incorporation of 32Pi into FnR on a molar basis (moles Pi/mole protein) is much less than for several other cellular proteins; that is, FnR is a poor substrate not only for protein kinase C, but for all ki~nases present in intact CHO cells. No stimulation of phosphorylation of FnR was observed consequent to PMA treatment (Fig. 6 A, compare lanes//and 12).
A similar result was found for the phosphorylation studies using broken cell preparations (Fig. 6 B) . The silver stain shows a complex pattern for the membrane-enriched, broken cell lysate (Fig. 6 B, lanes I and 2) and a strong band corresponding to FnR in the specific immunoprecipitate (Fig. 6 B, lanes 5 and 6). The identity of this band is confirmed in the immunoblot with anti-FnR antibody (Fig. 6 B, lanes 13  and 14) . In the autoradiogram, strong incorporation of 32Pi is observed in some of the bands of the lysate (Fig. 6 B, lanes  7 and 8) . However, no phosphorylation of the abundant FnR band is seen (Fig. 6 B, l a n e s / / a n d 12). Thus, the in vitro phosphorylation studies confirm the notion that FnR is a poor substrate for the array of kinases found in CHO cells.
Discussion
Phorbol ester treatment, presumably acting via stimulation of protein kinase C (39), has been reported to have diverse and contrary effects on cell morphology and adhesion. Both cell rounding and cytoskeletal disruption (51), as well as enhanced binding, adhesion, and cell spreading (5, 6, 28, 54) have been observed in different cell types. In this report we demonstrate a marked enhancement of integrin-mediated cell adhesion consequent to short exposure of CHO cells in suspension to phorbol ester (PMA).
CHO cells treated with PMA adhere more rapidly and more efficiently to substrata coated with the extracellular matrix proteins fibronectin, laminin, and vitronectin. We have previously shown that adhesion to fibronectin involves a specific, integrin-type, membrane receptor (7). CHO adhesion to nonspecific substrata (polylysine or Con A coated) is not noticeably affected by PMA treatment. PMA, thus, involve stimulation of receptor-mediated adhesion, but not global changes in membrane behavior leading to increased nonspecific adhesion.
In PMA-treated cells, the efficiency of ligand-mediated adhesion is enhanced (i.e., the dose-response curve for ligand is left shifted), while the potency of specific inhibitors of adhesion is decreased (curve for inhibitor is right shifted). This could suggest an increase in the number or affinity of the specific ligand receptor subsequent to PMA treatment. In the case of FnR this possibility has been clearly ruled out. Measurement of the affinity of receptor sites (using ~2sI-t~. bronectin), and of the number of cell surface receptors (using antireceptor monoclonal ~2~I-PB1 antibody or '25I-fibronectin), show that PMA treatment has no effect on these parameters. Thus, the locus of PMA effects on integrin-mediated cell adhesion seems not to be on the abundance or binding characteristics of the receptor, but rather seems to be subsequent to the initial ligand-receptor binding events. This is similar to the case of cAMP-dependent kinase regulation of cell adhesion (15, 16) , which takes place at the postreceptor level, but differs from tyrosine kinase regulation of adhesion which may directly affect binding characteristics of the FnR (11, 23).
It seems likely that integrins interact in some manner with cytoskeletal components during the formation of adhesive contacts (11-13). A possible mode of regulation of adhesion by protein kinase C could involve phosphorylation of the integrin, or of a cytoskeletal protein, in a manner leading to enhanced binding affinity between these two types of molecules. Thus we wished to investigate FnR phosphorylation subsequent to PMA treatment. Since talin is known to interact with integrins and is thought to link membrane integrins to cytoskeletal components (12, 13, 25) , we were interested in whether talin would become phosphorylated under conditions of PMA treatment that produced enhanced cell adhesion. However, we could not detect any enhanced phosphorylation of either talin or FnR due to PMA treatment of cells under treatment conditions which would result in marked stimulation of adhesion to fibronectin. Indeed, the FnR seems to be a very poor substrate, not only for protein kinase C but also for other kinases available in CHO cells. The receptor fails to incorporate detectable amounts of 32pi under in vivo or in vitro labeling conditions which lead to substantial incorporation of radiophosphate into other cell proteins.
Thus, the treatment of CHO cells with PMA markedly enhances integrin-mediated adhesion to fibronectin, without affecting nonspecific adhesion. Since PMA is a powerful agonist for protein kinase C, one might expect that PMA treatment could lead to phosphorylation of the FnR or of proteins known to interact with the receptor. This might result in changes in receptor expression at the cell surface, changes in the affinity of the receptor for fibronectin, or changes in the interaction between fibronectin receptor and cytoskeletal proteins or membrane proteins. Our results clearly rule out some of these important possibilities. PMA treatment does not result in altered expression or affinity of the FnR. Further, the receptor itself is quite a poor substrate for protein kinases. Thus, PMA modulation of adhesion, presuming it occurs through activation of protein kinase C, must involve the phosphorylation of other cellular proteins which interact directly or indirectly with the receptor during the adhesion process, rather than via phosphorylation of the receptor itself. Although talin might be a good candidate for such a protein, we were not able to detect PMA stimulation of 32pi-incorporation into talin in CHO cells under conditions which lead to PMA-enhanced cell adhesion.
In summary, it seems probable that the marked enhancement of cell adhesion to fibronectin consequent to PMA treatment stems from altered phosphorylation of cytoskeletal proteins, yet to be identified, which are critically involved in postreceptor steps of this integrin-dependent adhesion process. Efforts are underway to identify these critical components by examin/ttion of protein kinase substrates which are found in close association with FnR in cell-substratum adhesion sites.
